!
-2-Pyridyl-n-alkylphosphines
791
1
1
2
2
|
JCP| 12.2, C-12), 21.4 (d, | J | 16.8, C-10), 20.0 (d, | J | 15.6, C-13a), 18.7 (d, | J | 9.2,
CP
CP
CP
3
1
C-13b) ppm; P NMR (CDCl ): ꢁ 4.4 ppm; MS (EI): m/z (%) 251 (2), 236, 222, 208 (100), 166,
3
145, 132, 118, 106, 90, 76, 65, 51.
2
-(5-Diisopropylphosphino-pentyl)-pyridine (4b; C H NP)
1
6 28
3
Analogous to the procedure described above, 21.9 cm (35 mmol) MeLi, 4.14 g (35 mmol) (i-Pr) PH,
2
ꢀ
and 6.43 g (35 mmol) 3b yield 7.76 g (29 mmol, 84%) 4b after distillation (b.p.: 90 C at
�
6
4
Á 10 mbar) as a colourless liquid.
1
3
4
5
3
H NMR (CDCl ): ꢁ 8.50 (ddd, J 4.8, J 1.8, J 1.0, 1H, H-6), 7.55 (dt, J 7.7,
3
4
3
J 1.9, 1H, H-4), 7.08 (m, 2H, H-3/5), 2.76 (t, J 7.8, 2H, H-7), 1.71 (m, 2H, H-8), 1.67 (dsp,
3
3
2
J 7.0, J 2.9, 2H, H-13), 1.39±1.52 (m, 4H, H-9/10), 1.24±1.38 (m, 2H, H-11), 1.04 (dd,
HP
3
J
3
3
J
13
11.1, 6H, H-14b) ppm; C NMR
J 7.2,
13.8, 6H, H-14a), 1.02 (dd, J 7.0,
HP
HP
(
CDCl ): ꢁ 162.2 (C-2), 149.0 (C-6), 136.0 (C-4), 122.5 (C-3), 120.7 (C-5), 38.2 (C-7), 31.2 (d,
3
3
2 1
| 11.8, C-9), 29.5 (C-8), 27.9 (d, | J | 18.3, C-10), 23.1 (d, | J | 12.2, C-13), 21.4 (d,
|
|
J
CP
CP CP
2 2 31
1
JCP| 16.4, C-11), 20.0 (d, | J | 15.3, C-14a), 18.7 (d, | J | 9.2, C-14b) ppm; P NMR
CP
CP
(
CDCl ): ꢁ 4.4 ppm; MS (EI): m/z (%) 265 (13), 250, 222, 180, 173 (100), 160, 148, 132, 118,
3
1
06, 90, 76, 65, 43.
2
-(6-Diisopropylphosphino-hexyl)-pyridine (4c; C H NP)
1
7 30
3
1.9 cm (35 mmol) MeLi, 4.14 g (35 mmol) (i-Pr) PH, and 6.92 g (35 mmol) 3c yield 8.75 g
2
2
�
1 3 4 5 3
6
(
31 mmol, 89%) 4c after condensation at 4 Á 10 mbar into a cold trap as a colourless liquid.
H NMR (CDCl ): ꢁ 8.49 (ddd, J 4.9, J 1.8, J 0.9, 1H, H-6), 7.55 (dt, J 7.6,
3
4
3
3
4
5
J 1.9, 1H, H-4), 7.10 (d, J 7.5, 1H, H-3), 7.05 (ddd, J 7.4, J 4.8, J 1.2, 1H, H-5), 2.76
3
3
2
(
t, J 7.7, 2H, H-7), 1.71 (m, 2H, H-8), 1.67 (dsp, J 7.1, J 2.8, 2H, H-14), 1.20±1.50
HP
3 3 3 3
m, 8H, H-9/10/11/12), 1.04 (dd, J 7.2, J 13.9, 6H, H-15a), 1.01 (dd, J 6.9, J 11.1,
(
HP
HP
1
3
6
H, H-15b) ppm; C NMR (CDCl ): ꢁ 162.4 (C-2), 149.2 (C-6), 136.1 (C-4), 122.6 (C-3), 120.8
3
3 2
(
C-5), 38.4 (C-7), 31.4 (d, | J | 11.4, C-10), 29.8 and 29.1 (C-8/9), 28.1 (d, | J | 18.3, C-11),
CP
CP
1
1
2
2
3.2 (d, | J | 12.2, C-14), 21.6 (d, | J | 16.4, C-12), 20.1 (d, | J | 15.6, C-15a), 18.8 (d,
CP
CP
CP
2
31
JCP| 9.5, C-15b) ppm; P NMR (CDCl ): ꢁ 4.5 ppm; MS (EI): m/z (%) 279 (22), 264, 236,
|
3
1
94, 187 (100), 173, 162, 145, 132, 118, 106, 93, 90, 76, 65, 43.
2
-(7-Diisopropylphosphino-heptyl)-pyridine (4d; C H NP)
8 32
1
3
1.9 cm (35 mmol) MeLi, 4.14 g (35 mmol) (i-Pr) PH, and 7.41 g (35 mmol) 3d yield 6.93 g
2
2
ꢀ
1 3 4 5 3
� 4
(
24 mmol, 67%) 4d after distillation (b.p.: 124 C at 2 Á 10 mbar) as a colourless liquid.
H NMR (CDCl ): ꢁ 8.48 (ddd, J 4.9, J 1.8, J 1.0, 1H, H-6), 7.53 (dt, J 7.7,
3
4
3
3
4
5
J 1.9, 1H, H-4), 7.09 (d, J 7.7, 1H, H-3), 7.04 (ddd, J 7.5, J 5.0, J 1.2, 1H, H-5), 2.74
3
3
2
(
t, J 7.8, 2H, H-7), 1.69 (m, 2H, H-8), 1.66 (dsp, J 7.1, J 2.8, 2H, H-15), 1.24±1.45 (m,
HP
3
3
3
3
1
6
0H, H-9/10/11/12/13), 1.03 (dd, J 7.2, J 13.8, 6H, H-16a), 1.00 (dd, J 7.0, J 11.6,
HP
HP
1
3
H, H-16b) ppm; C NMR (CDCl ): ꢁ 162.4 (C-2), 149.1 (C-6), 136.1 (C-4), 122.6 (C-3), 120.8
3
3
(
C-5), 38.4 (C-7), 31.4 (d, | J | 11.4, C-11), 29.8 (C-8), 29.24 and 29.15 (C-9/10), 28.1 (d,
CP
2
1
1
2
|
JCP| 17.9, C-12), 23.2 (d, | J | 11.8, C-15), 21.5 (d, | J | 16.8, C-13), 20.1 (d, | J | 15.6,
CP
2 31
CP
CP
C-16a), 18.8 (d, | J | 9.1, C-16b) ppm; P NMR (CDCl ): ꢁ 4.4 ppm; MS (EI): m/z (%) 293
CP
3
(
14), 278, 250, 201, 187, 176, 162, 145, 132, 118, 106, 93, 90 (100), 76, 65, 61, 43.
2-(5-Diphenylphosphino-pentyl)-pyridine (4e; C H NP)
22 24
3
2.8 cm (20 mmol) n-BuLi, 3.80 g (20 mmol) Ph PH, and 3.75 g (20 mmol) 3b yield 4.92 g
1
2
ꢀ
ꢀ
(
15 mmol, 72%) 4e after crystallization from hexane at � 35 C as colourless crystals (m.p.: 44 C).